236 related articles for article (PubMed ID: 30333913)
41. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma.
Guo W; Zhao Y; Zhang Z; Tan N; Zhao F; Ge C; Liang L; Jia D; Chen T; Yao M; Li J; He X
Cancer Lett; 2011 Dec; 312(1):55-61. PubMed ID: 21906871
[TBL] [Abstract][Full Text] [Related]
42. Ferroptosis: process and function.
Xie Y; Hou W; Song X; Yu Y; Huang J; Sun X; Kang R; Tang D
Cell Death Differ; 2016 Mar; 23(3):369-79. PubMed ID: 26794443
[TBL] [Abstract][Full Text] [Related]
43. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
44. Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT.
Zhou Y; Yang J; Chen C; Li Z; Chen Y; Zhang X; Wang L; Zhou J
Front Pharmacol; 2021; 12():670224. PubMed ID: 34040532
[TBL] [Abstract][Full Text] [Related]
45. xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction.
Cobler L; Zhang H; Suri P; Park C; Timmerman LA
Oncotarget; 2018 Aug; 9(64):32280-32297. PubMed ID: 30190786
[TBL] [Abstract][Full Text] [Related]
46. Salubrinal Enhances Cancer Cell Death during Glucose Deprivation through the Upregulation of xCT and Mitochondrial Oxidative Stress.
Chen MC; Hsu LL; Wang SF; Pan YL; Lo JF; Yeh TS; Tseng LM; Lee HC
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572286
[TBL] [Abstract][Full Text] [Related]
47. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity.
Lewerenz J; Klein M; Methner A
J Neurochem; 2006 Aug; 98(3):916-25. PubMed ID: 16771835
[TBL] [Abstract][Full Text] [Related]
48. Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.
Takayama T; Kubo T; Morikawa A; Morita T; Nagano O; Saya H
Med Oncol; 2016 May; 33(5):45. PubMed ID: 27044355
[TBL] [Abstract][Full Text] [Related]
49. Burn injury induces the expression of cystine/glutamate transporter (x(c)(-)) in mouse T cells.
D'Elia M; Patenaude J; Dupras C; Bernier J
Immunol Lett; 2009 Aug; 125(2):137-44. PubMed ID: 19576933
[TBL] [Abstract][Full Text] [Related]
50. xCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammation.
Cai Y; Yang Q; Liao M; Wang H; Zhang C; Nambi S; Wang W; Zhang M; Wu J; Deng G; Deng Q; Liu H; Zhou B; Jin Q; Feng CG; Sassetti CM; Wang F; Chen X
Oncotarget; 2016 May; 7(21):31001-13. PubMed ID: 27129162
[TBL] [Abstract][Full Text] [Related]
51. Cystine/glutamate antiporter blockage induces myelin degeneration.
Soria FN; Zabala A; Pampliega O; Palomino A; Miguelez C; Ugedo L; Sato H; Matute C; Domercq M
Glia; 2016 Aug; 64(8):1381-95. PubMed ID: 27247047
[TBL] [Abstract][Full Text] [Related]
52. A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCT
Meira W; Daher B; Parks SK; Cormerais Y; Durivault J; Tambutte E; Pouyssegur J; Vučetić M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801101
[TBL] [Abstract][Full Text] [Related]
53. Enhanced expression of cystine/glutamate transporter in the lung caused by the oxidative-stress-inducing agent paraquat.
Kobayashi S; Kuwata K; Sugimoto T; Igarashi K; Osaki M; Okada F; Fujii J; Bannai S; Sato H
Free Radic Biol Med; 2012 Dec; 53(12):2197-203. PubMed ID: 23085521
[TBL] [Abstract][Full Text] [Related]
54. Antioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts.
Lassen N; Pappa A; Black WJ; Jester JV; Day BJ; Min E; Vasiliou V
Free Radic Biol Med; 2006 Nov; 41(9):1459-69. PubMed ID: 17023273
[TBL] [Abstract][Full Text] [Related]
55. Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells.
Iemata M; Takarada T; Hinoi E; Taniura H; Yoneda Y
J Cell Physiol; 2007 Dec; 213(3):721-9. PubMed ID: 17520696
[TBL] [Abstract][Full Text] [Related]
56. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.
Narang VS; Pauletti GM; Gout PW; Buckley DJ; Buckley AR
Chemotherapy; 2007; 53(3):210-7. PubMed ID: 17356269
[TBL] [Abstract][Full Text] [Related]
57. Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability.
Sha LK; Sha W; Kuchler L; Daiber A; Giegerich AK; Weigert A; Knape T; Snodgrass R; Schröder K; Brandes RP; Brüne B; von Knethen A
Free Radic Biol Med; 2015 Jun; 83():77-88. PubMed ID: 25687825
[TBL] [Abstract][Full Text] [Related]
58. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
Linher-Melville K; Haftchenary S; Gunning P; Singh G
Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
[TBL] [Abstract][Full Text] [Related]
59. Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407).
Shitara K; Doi T; Nagano O; Fukutani M; Hasegawa H; Nomura S; Sato A; Kuwata T; Asai K; Einaga Y; Tsuchihashi K; Suina K; Maeda Y; Saya H; Ohtsu A
Gastric Cancer; 2017 Nov; 20(6):1004-1009. PubMed ID: 28466360
[TBL] [Abstract][Full Text] [Related]
60. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
